33
Views
2
CrossRef citations to date
0
Altmetric
Commentary

How complete is “complete” molecular response in imatinib-treated chronic myeloid leukemia?

&
Pages 1230-1231 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hyun-Gyung Goh, Min Lin, Takashi Fukushima, Giuseppe Saglio, Dongho Kim, Soo-Young Choi, Soo-Hyun Kim, Jeong Lee, Young-Seok Lee, Sang-Mi Oh & Dong-Wook Kim. (2011) Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay. Leukemia & Lymphoma 52:5, pages 896-904.
Read now

Articles from other publishers (1)

Kate Vandyke, Stephen Fitter, Jenny Drew, Seiji FukumotoChristopher G. Schultz, Natalie A. Sims, David T. Yeung, Timothy P. Hughes & Andrew C. W. Zannettino. (2013) Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects. The Journal of Clinical Endocrinology & Metabolism 98:1, pages 67-76.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.